What Researchers Did
Researchers conducted a systematic review and meta-analysis to evaluate the efficacy and safety of hyperbaric oxygen therapy (HBOT) for retinal artery occlusion (RAO).
What They Found
The analysis included nine studies with 499 patients (286 HBOT, 213 non-HBOT), finding that HBOT was associated with improved best-corrected visual acuity (BCVA) with a mean difference of -0.63 (95% CI: -1.14 to -0.12). HBOT also demonstrated a generally favorable safety profile.
What This Means for Canadian Patients
This research suggests that hyperbaric oxygen therapy could be a promising treatment option for Canadian patients experiencing retinal artery occlusion, potentially improving their vision. However, more robust studies are needed before it can be widely adopted as a standard therapy.
Canadian Relevance
Although published in a Canadian journal, this meta-analysis did not include studies specifically conducted in Canada or with Canadian patient populations.
Study Limitations
The study's limitations include heterogeneity among the included studies and relatively small sample sizes.